Previous slide
Next slide
BioSpecialized™
Devoted to life-changing treatments
Our focus is simple, but our work is complex: making advanced, life-changing biologic medicines more accessible to more patients.
At Fresenius Kabi, we bring deep expertise in complex medicines, state-of-the-art supply chain and manufacturing capabilities, and above all, exceptional customer support to everything we do. That’s why our approach is BioSpecialized™.
Making life-changing therapies more affordable.
The Problem: The high cost of biologics.1
2% of people in the
U.S. use biologics
Biologics make up 40%
of total prescription drug
spending
The Solution: Biosimilars can potentially offer up to 30% price reductions when compared with reference products.2
- lnserro A. Enzi, Hassan introduce bipartisan bill to improve biosimilar education. American Journal of Managed Care (AJMC). Published May 27, 2019. Accessed May 20, 2022. https://www.centerforbiosimilars.com/view/enzi-hassan-introduce-bipartisan-bill-to-improve-biosimilar-education
- Kabir ER, Moreino SS, Siam MKS. The breakthrough of biosimilars: A twist In the narrative of biological therapy. Biomolecules. 2019;9{9):410. https://pubmed.ncbi.nlm.nih.gov/31450637/
We have launched biosimilars in Europe, Australia and Canada, turning the promise of
effective and affordable biologic therapies into reality for many patients. And, with an
extensive portfolio of intravenous and injectable medicines, plus over 100 years of
pharmaceutical experience and innovation, we are ideally positioned to deliver the
benefits of biosimilars to you and your patients.
Advanced science, manufacturing and support for biosimilars